This product detects familial Alzheimer's disease risk genes to help predict family-onset Alzheimer's disease risk in individuals, identify high-risk populations, and enable early prevention and intervention measures.
Manufactured by
Cygnus Biosciences (Beijing)Co., Ltd.
China
Cygnus Biosciences was founded by a team from Peking University including Academician Xie Xiaoliang. The company specializes in gene sequencing technology R&D, production and commercialization, with over 100 patents filed in China and internationally. Utilizing proprietary Fluorogenic and ECC error-correction coding sequencing technologies, Cygnus provides gene sequencing platforms and solutions for oncology, microbiology, reproductive health, and food safety applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 2 relevant products
Advanced Brain Monitoring, Inc.
South Korea · 1 relevant product
GENERI BIOTECH s.r.o.
Czech Republic · 3 relevant products
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →18 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 36 relevant matches
Shenzhen HaploX Biotechnology Co., Ltd. · China
A targeted genetic test for detecting Alzheimer's disease risk genes, particularly APOE variants. This test assesses genetic predisposition to Alzheimer's disease for early intervention planning.
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
A diagnostic test series for early detection of Alzheimer's disease, which is a progressive neurodegenerative disorder of the nervous system and the most common cause of dementia. The series detects key biomarkers including AD7C-NTP, tau protein, and β-amyloid protein, which are associated with the pathological features of Alzheimer's disease such as neurofibrillary tangles and amyloid plaques.
National Reference Laboratory · United Arab Emirates
Precision biomarker testing for early detection and monitoring of Alzheimer's disease and other dementias. This specialized service enables early intervention and prevention strategies for neurodegenerative conditions.
33 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products